The forced expression of AQP9 in patient-derived human-induced pluripotent stem cells differentiated into hepatocytes (hiPSCs-Heps), an in vitro model of OTCD, was shown to be effective in normalizing ureagenesis [106]. The gene discussed is AQP9; the disease is ornithine carbamoyltransferase deficiency.